Clinical Trial Update: An Open-label, Non-controlled Study of KHK4827 in Subjects With Psoriasis [Phase 3]

View source ↗

Summary

An open-label, non-controlled Phase 3 trial of KHK4827 in subjects with psoriasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• KHK4827

Snippet

Sponsor: Kyowa Kirin Co., Ltd. | Conditions: Psoriasis | Phase 3 | Status: COMPLETED